Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/116801
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNeumann, Joachim-
dc.contributor.authorHofmann, Britt-
dc.contributor.authorGergs, Ulrich-
dc.date.accessioned2024-10-08T07:39:56Z-
dc.date.available2024-10-08T07:39:56Z-
dc.date.issued2024-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/118760-
dc.identifier.urihttp://dx.doi.org/10.25673/116801-
dc.description.abstractThe present study examined three hallucinogenic amphetamine derivatives, namely, 2,5-dimethoxy-4-iodoamphetamine (DOI) as well as 2,5-dimethoxy-4-methylamphetamine (DOM) and 4-methylmethcathinone (mephedrone). The objective of this study was to test the hypothesis that DOI, DOM, and mephedrone would increase the contractile force in isolated human atrial preparations in a manner similar to amphetamine. To this end, we measured contractile force under isometric conditions in electrically stimulated (1 Hz) human atrial preparations obtained during open surgery. DOI and DOM alone or in the presence of isoprenaline reduced the contractile force concentration-dependently in human atrial preparations. These negative inotropic effects of DOM and DOI were not attenuated by 10 µM atropine. However, mephedrone increased the contractile force in human atrial preparations in a concentration- and time-dependent manner. Furthermore, these effects were attenuated by the subsequent addition of 10 µM propranolol or pretreatment with 10 µM cocaine in the organ bath. Therefore, it can be concluded that amphetamine derivatives may exert opposing effects on cardiac contractile force. The precise mechanism by which DOI and DOM exert their negative inotropic effects remains unknown at present. The cardiac effects of mephedrone are probably due to the release of cardiac noradrenaline.eng
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.ddc610-
dc.titleOpposite contractile effects of amphetamine-related hallucinogenic drugs in the isolated human atriumeng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleInternational journal of molecular sciences-
local.bibliographicCitation.volume25-
local.bibliographicCitation.issue16-
local.bibliographicCitation.publishernameMolecular Diversity Preservation International-
local.bibliographicCitation.publisherplaceBasel-
local.bibliographicCitation.doi10.3390/ijms25168887-
local.openaccesstrue-
dc.identifier.ppn1902471792-
cbs.publication.displayform2024-
local.bibliographicCitation.year2024-
cbs.sru.importDate2024-10-08T07:39:28Z-
local.bibliographicCitationEnthalten in International journal of molecular sciences - Basel : Molecular Diversity Preservation International, 2000-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
ijms-25-08887.pdf1.5 MBAdobe PDFThumbnail
View/Open